LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) NASDAQ:LBRX, a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced th…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.